Sequences are standardised representations of biological sequences, typically nucleotide (DNA/RNA) or amino acid (protein) sequences, that are included in patent…

A Briefing Paper Antibodies and their derivatives, including bispecific and multispecific antibodies, fragments, and fusion products, have become central to…

A recent EPO Board of Appeal (BoA) decision (T 1553/22) considered the patentability of human-animal chimeras (organisms or tissues that…

Abstract Shortly after celebrating its one-year anniversary, things look to be very much in full swing for the Unitary Patent…

Since the start of the COVID-19 pandemic there have been remarkable research and innovation efforts to fight the SARS-COV-2 virus….